SCHEMBL2065308

SCHEMBL2065308

COC(=O)c1ccc(-c2cc(Cl)c(C[C@@H]3CCN(N4CCCCC4)C3=O)c(Cl)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CHKA P35790 1/20 0.39
GLA P06280 1/20 0.38
TSHR P16473 1/20 0.38
KDM4E B2RXH2 1/20 0.37
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
CNR1 P21554 1/20 0.37
KMT2A Q03164 1/20 0.37
RAB9A P51151 4/20 0.36
CHRM4 P08173 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
NPC1 O15118 2/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
ATM Q13315 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2065309 1.00 ALDH1A1 (0.40) ALDH1A1L3MBTL1CHKAGLATSHR
SCHEMBL10026210 0.89 HRH3 (0.37) ALDH1A1KDM4EPDE4APDE4BPDE4C
SCHEMBL2065490 0.88 PDE4D (0.39) PDE4APDE4BPDE4CPDE4D
SCHEMBL2065488 0.88 PDE4D (0.39) PDE4APDE4BPDE4CPDE4D
SCHEMBL1092145 0.85 CHKA (0.34) ALDH1A1L3MBTL1CHKAPDE4APDE4B
SCHEMBL1092143 0.85 CHKA (0.34) ALDH1A1L3MBTL1CHKAPDE4APDE4B
SCHEMBL208480 0.84 HSD11B1 (0.45) ALDH1A1L3MBTL1CHKAGLATSHR
SCHEMBL2064354 0.83 HRH3 (0.40) ALDH1A1L3MBTL1TSHRKDM4EPDE4A
SCHEMBL2064352 0.83 HRH3 (0.40) ALDH1A1L3MBTL1TSHRKDM4EPDE4A
SCHEMBL1092828 0.81 GPR119 (0.37) ALDH1A1SMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016071-B1 INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-07-24 EP disclosed
US-8148534-B2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-04-03 US disclosed
US-20090275613-A1 INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275613-A1 INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD11B2, HSD3B1 ALDH1A1 100/4885L3MBTL1 3052/4885CHKA 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.